{
    "clinical_study": {
        "@rank": "95702", 
        "acronym": "CoCoNut", 
        "arm_group": {
            "arm_group_label": "Antiinfectives", 
            "description": "To analyze the efficacy of antiinfectives at high risk patients"
        }, 
        "brief_summary": {
            "textblock": "The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study\n      assessing risk factors, interventions, and outcome of immunosuppressed patients with or\n      without opportunistic infections."
        }, 
        "brief_title": "Cologne Cohort of Neutropenic Patients (CoCoNut)", 
        "completion_date": {
            "#text": "December 2050", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hematological Malignancies", 
            "Cancer", 
            "Chemotherapy", 
            "Neutropenia", 
            "Immunosuppression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Neutropenia", 
                "Opportunistic Infections", 
                "Hematologic Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "This prospective cohort was established with the aim of a comprehensive data collection of\n      all patients developing neutropenia after receiving chemotherapy for any kind of malignant\n      disease, treated in the University Hospital of Cologne."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  immunosuppressed patients\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "1 Year", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients developing neutropenia after receiving chemotherapy for any kind of malignant\n        disease, treated in the University Hospital of Cologne"
            }
        }, 
        "enrollment": {
            "#text": "100000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01821456", 
            "org_study_id": "!SZINF2", 
            "secondary_id": "!!SZINF2"
        }, 
        "intervention": {
            "arm_group_label": "Antiinfectives", 
            "description": "To analyze to efficacy of (novel) drug therapies", 
            "intervention_name": "Antiinfectives", 
            "intervention_type": "Drug", 
            "other_name": "Antifungals, Antibacterials, Antivirals"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Infective Agents", 
                "Antiviral Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hematological malignancies", 
            "cancer", 
            "chemotherapy", 
            "anti-infectives", 
            "treatment", 
            "outcome"
        ], 
        "lastchanged_date": "March 26, 2013", 
        "link": {
            "url": "http://innere1.uk-koeln.de/klinische-schwerpunkte/infektiologie"
        }, 
        "location": {
            "contact": {
                "email": "janne.vehreschild@ctuc.de", 
                "last_name": "J\u00f6rg Janne Vehreschild, Dr. med.", 
                "phone": "+0049 (0)221 478-6494", 
                "phone_ext": "-6494"
            }, 
            "contact_backup": {
                "email": "oliver.cornely@ctuc.de", 
                "last_name": "Oliver Andreas Cornely, Prof. Dr. med.", 
                "phone": "0049 (0)221 478-6494", 
                "phone_ext": "-6494"
            }, 
            "facility": {
                "address": {
                    "city": "Cologne", 
                    "country": "Germany", 
                    "state": "North Rhine-Westphalia", 
                    "zip": "50924"
                }, 
                "name": "University Hospital of Cologne"
            }, 
            "investigator": {
                "last_name": "J\u00f6rg J. Vehreschild, Dr. med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Cologne Cohort of Neutropenic Patients (CoCoNut) - a Non-interventional Cohort Study Assessing Risk Factors, Interventions, and Outcome of Immunosuppressed Patients With or Without Opportunistic Infections", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2050", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Long-term survival of hematology and oncology patients following neutropenia", 
            "safety_issue": "No", 
            "time_frame": "2 years following last follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01821456"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "20410061", 
            "citation": "Vehreschild JJ, R\u00fcping MJ, Wisplinghoff H, Farowski F, Steinbach A, Sims R, Stollorz A, Kreuzer KA, Hallek M, Bangard C, Cornely OA. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort. J Antimicrob Chemother. 2010 Jul;65(7):1466-71. doi: 10.1093/jac/dkq121. Epub 2010 Apr 21."
        }, 
        "source": "University Hospital of Cologne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital of Cologne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 1995", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}